Literature DB >> 2380359

Rapid focus reduction neutralization test of influenza A and B viruses in microtiter system.

Y Okuno1, K Tanaka, K Baba, A Maeda, N Kunita, S Ueda.   

Abstract

A rapid neutralization test for influenza A and B viruses was developed. In this method, a 96-well tissue culture plate was used for the preparation of cell monolayers and the peroxidase-antiperoxidase staining technique was used for the visualization of foci infected with these viruses. In the presence of trypsin and tragacanth gum, clear foci developed 1 day after infection. A linear relationship between virus dilutions and numbers of foci was observed. When neutralizing antibodies in some test sera were assayed, a good correlation was observed between the titers obtained by the focus method and those obtained by the ordinary plaque method. In addition, many serum specimens were investigated by the neutralization test, and it was demonstrated that the test is useful for serological studies of influenza.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2380359      PMCID: PMC267925          DOI: 10.1128/jcm.28.6.1308-1313.1990

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  20 in total

1.  Development of a micro-neutralization test for chikungunya virus.

Authors:  E Raharjo; M Tadano; Y Okamoto; Y Okuno
Journal:  Biken J       Date:  1986-03

2.  An improved micromethod for infectivity assays and neutralization tests of dengue viruses.

Authors:  T Ishimine; M Tadano; T Fukunaga; Y Okuno
Journal:  Biken J       Date:  1987-06

3.  Dissociation of the haemagglutination inhibition and the infectivity neutralization in the reactions of influenza A/USSR/90/77 (H1N1) virus variants with monoclonal antibodies.

Authors:  A K Gitelman; N V Kaverin; I G Kharitonenkov; I A Rudneva; E L Sklyanskaya; V M Zhdanov
Journal:  J Gen Virol       Date:  1986-10       Impact factor: 3.891

4.  Micro-neutralization test for mumps virus using the 96-well tissue culture plate and PAP (peroxidase-antiperoxidase) staining technique.

Authors:  Y Okuno; K Yamanishi; S Lwin; M Takahashi
Journal:  Microbiol Immunol       Date:  1985       Impact factor: 1.955

5.  Antibody response in humans to influenza virus type B host-cell-derived variants after vaccination with standard (egg-derived) vaccine or natural infection.

Authors:  M W Harmon; P A Rota; H H Walls; A P Kendal
Journal:  J Clin Microbiol       Date:  1988-02       Impact factor: 5.948

6.  Biological activity of monoclonal antibodies to operationally defined antigenic regions on the hemagglutinin molecule of A/Seal/Massachusetts/1/80 (H7N7) influenza virus.

Authors:  H Kida; L E Brown; R G Webster
Journal:  Virology       Date:  1982-10-15       Impact factor: 3.616

7.  Evaluation of focus reduction neutralization test with peroxidase-antiperoxidase staining technique for hemorrhagic fever with renal syndrome virus.

Authors:  O Tanishita; Y Takahashi; Y Okuno; K Yamanishi; M Takahashi
Journal:  J Clin Microbiol       Date:  1984-12       Impact factor: 5.948

8.  Rapid focus reduction neutralization test of Japanese encephalitis virus in microtiter system. Brief report.

Authors:  Y Okuno; T Fukunaga; M Tadano; Y Okamoto; T Ohnishi; M Takagi
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

9.  Trial of inactivated Japanese encephalitis vaccine in children with underlying diseases.

Authors:  A Yamada; J Imanishi; R F Juang; T Fukunaga; Y Okuno; M Tadano; K Fukai; K Baba; H Yabuuchi
Journal:  Vaccine       Date:  1986-03       Impact factor: 3.641

10.  A sensitive plaque inhibition technique for assay of antibodies to influenza virus: use to detect previous antigenic priming with influenza viruses.

Authors:  Z Zakay-Rones; E Margalith; R Levy; E Katz
Journal:  J Virol Methods       Date:  1980       Impact factor: 2.014

View more
  51 in total

1.  Variation of the conserved neutralizing epitope in influenza B virus victoria group isolates in Japan.

Authors:  Naoko Nakagawa; Ritsuko Kubota; Yoshinobu Okuno
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

2.  Discovery of the neutralizing epitope common to influenza B virus victoria group isolates in Japan.

Authors:  Naoko Nakagawa; Jun Suzuoki; Ritsuko Kubota; Shinzo Kobatake; Yoshinobu Okuno
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

3.  Cocirculation of antigenic variants and the vaccine-type virus during the 2004-2005 influenza B virus epidemics in Japan.

Authors:  Naoko Nakagawa; Natsumi Higashi; Toshimasa Nakagawa
Journal:  J Clin Microbiol       Date:  2008-12-17       Impact factor: 5.948

4.  A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains.

Authors:  Y Okuno; Y Isegawa; F Sasao; S Ueda
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

5.  Application of subtype-specific monoclonal antibodies for rapid detection and identification of influenza A and B viruses.

Authors:  M Ueda; A Maeda; N Nakagawa; T Kase; R Kubota; H Takakura; A Ohshima; Y Okuno
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

6.  Influenza B virus victoria group with a new glycosylation site was epidemic in Japan in the 2002-2003 season.

Authors:  Naoko Nakagawa; Ritsuko Kubota; Akiko Maeda; Yoshinobu Okuno
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

7.  Recombinant bovine conglutinin, lacking the N-terminal and collagenous domains, has less conglutination activity but is able to inhibit haemagglutination by influenza A virus.

Authors:  S Eda; Y Suzuki; T Kase; T Kawai; K Ohtani; T Sakamoto; T Kurimura; N Wakamiya
Journal:  Biochem J       Date:  1996-05-15       Impact factor: 3.857

8.  Reproducibility of serologic assays for influenza virus A (H5N1).

Authors:  Iain Stephenson; Alan Heath; Diane Major; Robert W Newman; Katja Hoschler; Wang Junzi; Jacqueline M Katz; Jerry P Weir; Maria C Zambon; John M Wood
Journal:  Emerg Infect Dis       Date:  2009-08       Impact factor: 6.883

9.  Mutations at positions 186 and 194 in the HA gene of the 2009 H1N1 pandemic influenza virus improve replication in cell culture and eggs.

Authors:  Pirada Suphaphiphat; Michael Franti; Armin Hekele; Anders Lilja; Terika Spencer; Ethan Settembre; Gene Palmer; Stefania Crotta; Annunziata B Tuccino; Bjoern Keiner; Heidi Trusheim; Kara Balabanis; Melissa Sackal; Mithra Rothfeder; Christian W Mandl; Philip R Dormitzer; Peter W Mason
Journal:  Virol J       Date:  2010-07-14       Impact factor: 4.099

10.  Significant neutralizing activity of human immunoglobulin preparations against pandemic 2009 H1N1.

Authors:  Mikihiro Yunoki; Ritsuko Kubota-Koketsu; Takeru Urayama; Tadahiro Sasaki; Du Analiwa; Yuko Konoshima; Shoji Ideno; Yuki Fukunaga; Saeko Morikawa; Satoshi Hiroi; Kazuo Takahashi; Yoshinobu Okuno; Katsuro Hagiwara; Kazuyoshi Ikuta
Journal:  Br J Haematol       Date:  2009-11-24       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.